1National Kidney Foundation.K/DOQI clinical practice guidelines on hypertension and antihypertensive agents in chronic kidney disease.Am J Kidney Dis,2004(Suppl 1),43:S65-S223.
2Hyman DJ,Pavlik VN.Characteristics of patients with uncontrolled hypertension in the United States.N Engl J Med,2001,345:479-486.
3Prevalence of chronic kidney disease and decreased kidney function in the adult U.S.population:Third National Health and Nutrition examination Survey.Am J Kidney Dis,2003 (Suppl 2),41:S29-S40.
4Ljungman S,Wikstrand J,Hartford M,et al.Urinary albumin excretion-a predictor of risk of cardiovascular disease.A prospective 10-year follow-up of middle-aged nondiabetic normal and hypertensivemen.Am J Hypertens,1996,9:770-778.
5UKPDS Study Group.Efficacy of atenolol and captopril in reducing risk of macrovascular and microvascular complications in type 2 diabetes:UKPDS 39.UK Prospective Diabetes Study Group.BMJ,1998,317:713-720.
6Lewis E J,Hunsicker LG,Bain RP,et al.The effect of angiotensinconvertingenzyme inhibition on diabetic nephropathy.N Engl J Med,1993,329:1456-1462.
7The Hope Trial Investigators.Effects of ramipril on cardiovascular andmicrovascular outcomes in people with diabetes mellitus:Results of the HOPE study and MICRO-HOPE substudy.Heart Outcomes Prevention Evaluation Study Investigators.Lancet,2000,22:355:253-259.
8Hansson L,Lindholm LH,Niskanen L,et al.Effect of angiotensinconverting-enzyme inhibition compared with conventional therapy on cardiovascular morbidity and mortality in hypertension:The Cap-topril Prevention Project (CAPPP) randomised trial.Lancet,1999,353:611 -616.
9Estacio RO,Jeffers BW,Hiatt WR,et al.The effect of nisoldipine as compared with enalapril on cardiovascular outcomes in patients with non-insulin-dependent diabetes and hypertension.N Engl J Med,1998,338:645-652.
10.Tatti P,Pahor M,Byington RP,et al.Outcome results of the Fosinopril Versus Amlodipine Cardiovascular Events Randomized Trial (FACET) in patients with hypertension and NIDDM.Diabetes Care,1998,21:597-603.
3Johnston PA, Davison AM. hypertension in adults with idiopathic glomerulonephritis and normal serum creatinine. A report from the MRC Glomerulonephritis Registry. Nephrol Dial Transplant, 1993,8:20.
4Salem MM.Hypertension in the hemodialysis population: A survey of patients.Am J Kidney Dis, 1995,26:461.
5LI Leishi . End-stage renal disease in china. Kidney Int,1996,49:287.
6Coleman TG, Guyton AC. Hypertension caused by salt loading in the dog. 3. Onset transients of cardiac output and other circulatory variables. Circ Res, 1996,25:153.
7Blumberg A,Nelp WB,Hegstrom RM et al. Extracellular volume in patients with chronic renal disease treated for hypertension by sodium restriction . Lancet,1969,2:69.
8Muniz P, Fortuno A, Zalba G et al.Effects of loop diuretics on angiotensin Ⅱ-stimulated vascular smooth miscle cell growth .Nephrol Dial Transplant,2001,16( Suppl1 ) : 14.
9Charra B, Calemard E, Ruffet M et al.Survival as an index of adquacy of dialysis.Kidney Int,1992,41:1286.
10Boer P,Dorhout Mees EJ, Roos JC et al.Renin and body fluid volumes in chronic renal disease. Relations between arterial pressure,plasma rennin activity,blood volume,and extracellular volume in chronic renal disease, as compared with essential hypertention. Acta Med Scand, 1981,210:207.
